TRPM2 and metabolic dysfunction-associated steatotic liver disease: Given the important role played by ROS in the development of non-alcoholic fatty liver disease and hepatocellular carcinoma, it is very likely that liver cell TRPM2 channels, activated by ROS, are involved (reviewed in [1,10]).